Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
Clinical trial NCT01438554 · COMPLETED
Trial details
- NCT number
- NCT01438554
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2016-04-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.